Validation-Ready AI for GxP Operations in Pharma Sep 19, 2025 Validation-ready AI under GAMP 5: classification for ML, continuous validation lifecycle, V-model evidence, and controls for AI-specific risks. Read more →
Pharma's EU AI Act Playbook: GxP-Ready Steps Sep 24, 2025 How the EU AI Act maps onto GxP work in pharma: risk tiers, GPAI duties, codes of practice, and audit-ready execution without a parallel quality system. Read more →
Computer System Validation in Pharma: What Engineering Teams Need to Implement May 7, 2026 Computer system validation in pharma: when full CSV applies, when CSA's risk-based path is enough, and what each delivers for AI/ML systems. Read more →
Approval-Grade Evidence: Engineering AI for Audit, Procurement, and Regulated Review Jun 12, 2026 Approval-grade evidence for AI is an engineering output, not a policy document. What goes in the pack, who signs it, and how rubrics map to artefacts. Read more →